From: Pain management in German hospices: a cross-sectional study
Form of application | Total (n = 146) | % |
---|---|---|
Oral long-acting | 142 | 97.3% |
Oral short-acting | 142 | 97.3% |
Subcutaneous | 142 | 97.3% |
Transdermal | 140 | 95.9% |
Intravenous | 137 | 93.8% |
Buccal | 121 | 82.9% |
Nasal | 105 | 71.9% |
Others | 20 | 13.7% |